Analysis of the current state of postoperative patient-controlled analgesia in Korea.
10.17085/apm.2016.11.1.28
- Author:
Kye Min KIM
1
Author Information
1. Department of Anesthesiology and Pain Medicine, Inje University Sanggye Paik Hospital, Seoul, Korea. kyemin@paik.ac.kr
- Publication Type:Original Article
- Keywords:
Patient-controlled analgesia;
Postoperative pain
- MeSH:
Analgesia;
Analgesia, Patient-Controlled*;
Fentanyl;
Korea*;
Pain Clinics;
Pain Measurement;
Pain, Postoperative;
Passive Cutaneous Anaphylaxis;
Pharmacology
- From:Anesthesia and Pain Medicine
2016;11(1):28-35
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
BACKGROUND: Patient-controlled analgesia (PCA) is a widely used method of postoperative analgesia with the advantage of tailored dosing for each individual. In spite of its popularity, there have been few reports on the current state of PCA in Korea. In this study, the data on PCA management and PCA regimens of medical institutions in Korea were collected and analyzed. METHODS: Members of the Korean Society for Anesthetic Pharmacology were questioned as to the state of postoperative PCA management, such as acute pain services (APS) and pain assessment. A list of PCA regimens for each institution was also requested and analyzed. RESULTS: Among 65 hospitals, APS was run in 30 and the severity of postoperative pain was assessed in 60. The safety and efficacy of PCA was evaluated only in 9 hospitals. A total 518 PCA regimens were reported (414, 95 and 9 regimens for intravenous, epidural and other routes, respectively). For intravenous PCA, fentanyl only and fentanyl-ketorolac regimens comprised 33.8 and 30.9% of treatments, respectively. In 95.9% of the regimens, background infusion was used. For epidural PCA, fentanyl-ropivacaine or fentanyl-levobupivacaine regimens made up the majority (47.4 and 13.7%, respectively). CONCLUSIONS: In Korea, APS was used in less than 50% of the hospitals and the evaluation of the safety and efficacy of PCA is not carried out in the majority. Background infusion, known to have little advantage in most cases, was widely used in intravenous PCA.
